Use, Safety, and Efficacy of Single-Patient Use of the US Food and Drug Administration Expanded Access Program.

Feit, Noah Z

Use, Safety, and Efficacy of Single-Patient Use of the US Food and Drug Administration Expanded Access Program. [electronic resource] - JAMA oncology Apr 2019 - 570-572 p. digital

Publication Type: Journal Article

2374-2445

10.1001/jamaoncol.2018.7002 doi


Adolescent
Adult
Antineoplastic Agents--adverse effects
Compassionate Use Trials--statistics & numerical data
Drugs, Investigational--adverse effects
Female
Humans
Male
Middle Aged
Neoplasms--drug therapy
Program Evaluation
Treatment Outcome
United States
United States Food and Drug Administration
Young Adult